Angelman Syndrome
Rare Disease·MeSH: Angelman Syndrome
Prevalence
5.0 / 100K
4 drugs in development·3 companies·8 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ion582 | IONIS PHARMACEUTICALS INC (IONS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Angelman Syndrome?
BioSniper tracks 4 drugs in development for Angelman Syndrome across 3 companies.
How many clinical trials target Angelman Syndrome?
There are 8 clinical trials targeting Angelman Syndrome tracked by BioSniper.
What is the prevalence of Angelman Syndrome?
The estimated prevalence of Angelman Syndrome is approximately 5.0 per 100,000 population.
Deep-dive into Angelman Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis